Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck Serono

Showing 15 posts of 72 posts found.

First oral MS treatment approved in Russia

July 12, 2010
Sales and Marketing Cladribine, MS, Merck Serono, Movectro

Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …

News

Trials of cancer vaccine Stimuvax can resume

June 17, 2010
Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines

Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …

News

Erbitux ‘now standard of care’ in KRAS patients

June 3, 2010
Sales and Marketing Erbitux, Merck Serono

A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …

News

Global MS awareness campaign launched

June 1, 2010
Medical Communications MS, Merck Serono

Merck Serono has launched a short film competition as part of a global campaign, Real MS, to raise awareness of …

News

Trial boost for Merck KGaA’s cladribine

April 19, 2010
Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

News

Adverse event halts Merck cancer vaccine trial

March 23, 2010
Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …

News
US PKU website

Digital Pharma: Merck Serono expands PKU website

March 16, 2010
Medical Communications Kuvan, Merck Serono, PKU

Merck Serono has expanded its European phenylketonuria disease awareness website, adding versions in French and Spanish. The website was originally …

News
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010
Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …

News

Merck KGaA posts modest revenue increase

February 24, 2010
2009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif

German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth.  Revenues increased 2.1% to 7.7 …

News
Merck Serono

Cladribine still set to be first oral MS treatment

January 18, 2010
Sales and Marketing Cladribine, FTY-720, MS, Merck Serono

Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …

News

Cancer Research UK and Merck KGaA to co-develop leukaemia candidate

January 4, 2010
Research and Development Merck Serono, leukaemia, oncology

Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …

News
MerckKgAaHQ

Merck Serono opens Beijing R&D centre

November 24, 2009
Research and Development China, Merck Serono, em

 China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …

News
Solvay Pharma on Twitter

Digital Pharma: Byte-sized roundup

November 13, 2009
Medical Communications Merck Serono, Solvay, Twitter, bing, digi, digital, digital pharma, google

Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based …

Feature
Solvay's Russian Twitter account

Digital Pharma: Byte-sized roundup

November 13, 2009
Medical Communications FDA, Merck Serono, Solvay, digital pharma, google, social media

Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based …

News

Merck KGaA’s rising revenues fail to lift bottom line

October 27, 2009
Sales and Marketing Merck Serono

 Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026